GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cilo Cybin Holdings Ltd (JSE:CCC) » Definitions » Other Stockholders Equity

Cilo Cybin Holdings (JSE:CCC) Other Stockholders Equity : R0.00 Mil (As of Mar. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Cilo Cybin Holdings Other Stockholders Equity?

Cilo Cybin Holdings's Other Stockholders Equity for the quarter that ended in Mar. 2023 was R0.00 Mil.


Cilo Cybin Holdings Other Stockholders Equity Historical Data

The historical data trend for Cilo Cybin Holdings's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cilo Cybin Holdings Other Stockholders Equity Chart

Cilo Cybin Holdings Annual Data
Trend Mar22 Mar23
Other Stockholders Equity
- -

Cilo Cybin Holdings Semi-Annual Data
Mar22 Mar23
Other Stockholders Equity - -

Cilo Cybin Holdings Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Cilo Cybin Holdings Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cilo Cybin Holdings's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Cilo Cybin Holdings Business Description

Traded in Other Exchanges
N/A
Address
7 Sterling Street, The Point Office Park, Unit C1, Samrand, Pretoria, GT, ZAF, 0157
Cilo Cybin Holdings Ltd is a Company whose core focus is on supplying GMP medical cannabis products, including GMP CBD, CBG, CBN isolates and GMP THC and CBD distillates to meet the highest standards of quality, effectiveness, care, and safety. It specializes in supplying medical-grade cannabis flower and final products, using a cold ethanol extraction process with high-quality input materials.

Cilo Cybin Holdings Headlines

No Headlines